title: [Oxytocin for the prophylaxis of uterine atony after cesarean delivery. Should we reconsider our protocols?].
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital Universitario La Paz, Madrid, España. Electronic address: casinunca@hotmail.com.
authors.forename: R
authors.initials: R
authors.lastname: Schiraldi
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital Universitario La Paz, Madrid, España.
authors.forename: E
authors.initials: E
authors.lastname: Guasch
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced; D002585:Cesarean Section; D002985:Clinical Protocols; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D010120:Oxytocics / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D010121:Oxytocin / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D010656:Phenylephrine / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control*; D006473:Postpartum Hemorrhage / Q000517:prevention & control; D011247:Pregnancy; D012307:Risk Factors; D014593:Uterine Inertia / Q000517:prevention & control*; D014664:Vasodilation / Q000187:drug effects
chemical_list: D010120:Oxytocics; D010656:Phenylephrine; D010121:Oxytocin